{"data":{"id":"us-nm/26-4-2","jurisdiction":"us-nm","citation":"26-4-2","heading":"Definitions.","body":"As used in the Wholesale Prescription Drug Importation Act:\nA. \"Canadian supplier\" means a manufacturer, wholesale distributor or pharmacy that is appropriately licensed or permitted under Canadian federal or provincial laws and rules to manufacture, distribute or dispense prescription drugs;\nB. \"committee\" means the prescription drug importation advisory committee;\nC. \"department\" or \"authority\" means the health care authority department;\nD. \"eligible prescription drug\" means a drug eligible for importation that:\n(1) meets the United States food and drug administration's standards related to safety, effectiveness, misbranding and adulteration;\n(2) does not violate federal patent laws;\n(3) is expected to generate cost savings; and\n(4) is not a controlled substance;\nE. \"program\" means the wholesale prescription drug importation program; and\nF. \"state drug wholesaler\" means a licensed wholesale drug distributor that contracts with the state to import eligible prescription drugs from a Canadian supplier.","path":["Chapter 26 - Drugs and Cosmetics","ARTICLE 4 Wholesale Prescription Drug Importation"],"source_url":"https://nmonesource.com/nmos/nmsa-unanno/en/item/18526/index.do","current_through":"2025-12-31","vintage":"","retrieved_at":"2026-09-03T15:02:19Z","sha256":"8608e41481f69854079b6290d49afe8fc176dd2ff4ff593360cedec24c99c851","source_id":"us-nm","stale":false,"prev":"us-nm/26-4-1","next":"us-nm/26-4-3"},"notice":"GroundRules: Original legal text. Not legal advice."}